Press Releases Year None2023202220212020201920182017 June 3, 2017 Anti-tumor Activity Observed in Phase 1 Trial of Novel P53-Targeting Drug ALRN-6924 Read More May 18, 2017 Aileron Therapeutics Announces Oral Presentation at ASCO on ALRN-6924 Targeting p53 Read More First page « Previous page ‹ … Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Current page 12